HomeInsights52 Week High Stocks

Beta Drugs Ltd 52 Week High

Beta Drugs Ltd 52 Week High

stocks purchased

₹ 0.9 Cr

Volume transacted

stocks purchased

5.0 K

stocks traded

Last Updated time: 18 Sep 9.00 AM

Image

Beta Drugs Ltd

NSE: BETA

YEARHIGH

1985

Last updated: 18 Sep 24

Key Highlights

  • The 52 Week HIGH of Beta Drugs Ltd is ₹ 1985 as of 18 Sep 24.

Company Fundamentals for Beta Drugs Ltd

No data available

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Beta Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
18 Sep 20241758
17 Sep 20241816
16 Sep 20241816.65
13 Sep 20241822.45
12 Sep 20241733.2
11 Sep 20241759.9
10 Sep 20241850.55
09 Sep 20241710.25
06 Sep 20241775
05 Sep 20241806.8

Asset Value vs Market Value of Beta Drugs Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Beta Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Beta Drugs Ltd

No data available

* All values are in crore

Beta Drugs Ltd News Hub

News

Beta Drugs schedules AGM

Beta Drugs announced that the 19th Annual General Meeting (AGM) of the company will be hel...

Read more

02 Sep 202417:17

News

Beta Drugs to discuss results

Beta Drugs will hold a meeting of the Board of Directors of the Company on 14 May 2024 Pow...

Read more

07 May 202412:58

News

Beta Drugs to table results

Beta Drugs will hold a meeting of the Board of Directors of the Company on 7 November 2023...

Read more

01 Nov 202316:05

News

Beta Drugs AGM scheduled

Beta Drugs announced that the 18th Annual General Meeting (AGM) of the company will be hel...

Read more

05 Sep 202315:24

News

Beta Drugs to discuss results

Beta Drugs will hold a meeting of the Board of Directors of the Company on 8 May 2023. Pow...

Read more

26 Apr 202314:03

News

Beta Drugs to table results

Beta Drugs will hold a meeting of the Board of Directors of the Company on 27 October 2022...

Read more

18 Oct 202213:52

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for 52 Week High of Beta Drugs Ltd

What is the significance of Beta Drugs Ltd reaching its 52-week high?

Beta Drugs Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Beta Drugs Ltd 52-week high?

Investors monitor Beta Drugs Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Beta Drugs Ltd a good buy when it hits its 52-week high?

Whether Beta Drugs Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Beta Drugs Ltd fundamentals.

What should I consider before investing in Beta Drugs Ltd at its 52-week high?

Before investing in Beta Drugs Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Beta Drugs Ltd stock price continue to rise after reaching its 52-week high?

Beta Drugs Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*